CoChat

Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition

Published version of a preprint

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

The CRL4 CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4 CRBN through next-generation molecular glue degraders.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.adt6736

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. O. S. Smart, G. Bricogne, Multifaceted Roles of Crystallography in Modern Drug Discovery, NATO Science for Peace and Security Series (Springer, 2015), pp. 165–181.

Cited by

See all 117

Metadata

Authors
Petzold, G., Gainza, P., Annunziato, S., Lamberto, I., Trenh, P., McAllister, L. A., DeMarco, B., Schwander, L., Bunker, R. D., Zlotosch, M., SriRamaratnam, R., Gilberto, S., Langousis, G., Donckele, E. J., Quan, C., Strande, V., De Donatis, G. M., Alabi, S. B., Alers, J., Matysik, M., Staehly, C., Dubois, A., Osmont, A., Garskovas, M., Lyon, D., Wiedmer, L., Oleinikovas, V., Lieberherr, R., Rubin, N. T., Lam, D. T., Lucas, X., Liardo, E., Widlund, N. I., Ritzén, A., Caceres, R. M., Vigil, D., Tsai, J., Wallace, O., Peluso, M., Sadok, A., Tiedt, R., Paterson, A. M., Zarayskiy, V., Fasching, B., Bonenfant, D., Warmuth, M., Castle, J. C., & Townson, S. A.
Affiliations
  • Boston Foundation (US)
  • Monte Rosa Therapeutics Inc, Boston, MA, USA.
Corresponding author
  • Petzold, Georg
  • Castle, John C.
  • Townson, Sharon A.
Venue
Science
Published
2025-07-03
Volume
389
Issue
6755
Pages
eadt6736-eadt6736
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4411983851
Cited by
117
References
73
Citations by year
2026: 73 · 2025: 43
FWCI
34.63
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
molecular glues, Vav1, protein degradation
MeSH terms
Humans, Protein Binding, Substrate Specificity, Molecular Mimicry, Amino Acid Motifs, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Data Mining, Drug Repositioning, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.